Ethosomes® and transfersomes® containing linoleic acid: Physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders

Biomedical Microdevices

Volumn 14, Issue 1, 2012, Pages 119-130

  Celia, Christian ^a,b   Cilurzo, Felisa ^b   Trapasso, Elena ^b   Cosco, Donato ^b   Fresta, Massimo ^b   Paolino, Donatella ^b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Colloidal stability; Ethosomes ; Hyperpigmentation disorders; Linoleic acid; Ultradeformable liposomes

Indexed keywords

ACTIVE COMPOUNDS; ACTIVE INGREDIENTS; COLLOIDAL CARRIERS; COLLOIDAL STABILITY; DRUG RELEASE; ETHOSOMES; HYPERPIGMENTATION; LINOLEIC; LIPID COMPOSITION; MEAN SIZE; MEMBRANE MODELS; PERCUTANEOUS PERMEATION; PHOTON BACK-SCATTERING; PHYSICO-CHEMICAL CHARACTERIZATION; POTENTIAL SYSTEMS; SODIUM CHOLATE; TECHNOLOGICAL FEATURE; TECHNOLOGICAL PARAMETERS; THERAPEUTIC TREATMENTS; TOPICAL DELIVERY; TOPICAL DRUGS; TOPICAL TREATMENTS;

DRUG PRODUCTS; ETHANOL; LIPOSOMES; PERMEATION; PHOSPHOLIPIDS; SKIN; SODIUM; UNSATURATED FATTY ACIDS; ZETA POTENTIAL;

LINOLEIC ACID;

ALCOHOL; CHOLIC ACID; DRUG CARRIER; ETHOSOMES; LINOLEIC ACID; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPON 100 G; TRANSFERSOMES; UNCLASSIFIED DRUG;

ANALYTICAL EQUIPMENT; ARTICLE; BIOTECHNOLOGY; CHLOASMA; COLLOID; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG STABILITY; EPIDERMIS; HUMAN; HUMAN CELL; LIGHT SCATTERING; LIPID COMPOSITION; LIPID VESICLE; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRATUM CORNEUM; ZETA POTENTIAL;

ADMINISTRATION, TOPICAL; COLLOIDS; DRUG CARRIERS; ETHANOL; HUMANS; LINOLEIC ACID; MELANOSIS; PHOSPHOLIPIDS; PHYSICOCHEMICAL PHENOMENA; SODIUM CHOLATE; SOLUBILITY;

EID: 84857789742     PISSN: 13872176     EISSN: 15728781     Source Type: Journal    
DOI: 10.1007/s10544-011-9590-y     Document Type: Article

References (56)

1. D Ainbinder E Touitou 2005 Drug Deliv 12 297 10.1080/10717540500176910 (Pubitemid 41356186)
2. H Ando Y Funasaka M Oka A Ohashi M Furumura J Matsunaga N Matsunaga VJ Hearing M Ichihashi 1999 J Lipid Res 40 1312
3. ER Bendas MI Tadros 2007 AAPS PharmSciTech 8 E107 10.1208/pt0804107
4. HA Benson 2006 Expert Opin. Drug Deliv 3 727 10.1517/17425247.3.6.727 (Pubitemid 44781845)
5. C Celia E Trapasso D Cosco D Paolino M Fresta 2009 Colloids Surf B Biointerfaces 72 155 10.1016/j.colsurfb.2009.03.007
6. C Celia MG Calvagno D Paolino S Bulotta CA Ventura D Russo M Fresta 2008 J Nanosci Nanotechnol 8 2102 10.1166/jnn.2008.065
7. G Cevc 2004 Adv Drug Deliv Rev 56 675 10.1016/j.addr.2003.10.028 (Pubitemid 38326939)
8. G Cevc 2003 Clin Pharmacokinet 42 461 10.2165/00003088-200342050-00004 (Pubitemid 36649039)
9. G Cevc D Gebauer 2003 Biophys J 84 1010 10.1016/S0006-3495(03)74917-0
10. G Cevc G Blume 2001 Biochim Biophys Acta 1514 191 10.1016/S0005-2736(01) 00369-8 (Pubitemid 32831008)
11. G. Cevc. Patent WO 00/38653; A61K 9/127 (2000)
12. R Charlín CB Barcaui BK Kac DB Soares R Rabello-Fonseca L Azulay-Abulafia 2008 Int J Dermatol 47 19 10.1111/j.1365-4632.2007.03351.x
13. YA Cho HS Gwak 2004 Drug Dev Ind Pharm 30 557 10.1081/DDC-120037486 (Pubitemid 38924625)
14. N Dayan E Touitou 2000 Biomaterials 21 1879 10.1016/S0142-9612(00)00063-6 (Pubitemid 30398506)
15. V Dubey D Mishra NK Jain 2007 Eur J Pharm Biopharm 67 398 10.1016/j.ejpb.2007.03.007 (Pubitemid 47211909)
16. GM El Maghraby AC Williams BW Barry 2006 J Parm Pharmacol 58 415 10.1211/jpp.58.4.0001
17. MM Elsayed G Cevc 2011 Biochim Biophys Acta 1808 140 10.1016/j.bbamem. 2010.09.002
18. GM El Zaafarany GA Awad SM Holayel ND Mortada 2010 Int J Pharm 397 164 10.1016/j.ijpharm.2010.06.034
19. M Fresta G Puglisi 1997 J Control Release 44 141 10.1016/S0168-3659(96) 01519-2 (Pubitemid 27039111)
20. M Fresta G Puglisi 1996 J Drug Target 4 95 10.3109/10611869609046267
21. B Godin E Touitou 2004 J Control Release 94 365 10.1016/j.jconrel.2003. 10.014 (Pubitemid 38117147)
22. B Godin E Touitou 2005 Curr Drug Deliv 2 269 10.2174/1567201054367931 (Pubitemid 40943999)
23. B. Godin, E. Touitou, Crit Rev Ther Drug Carrier Syst 20, 63 (2003)
24. A González-Paredes M Manconi C Caddeo A Ramos-Cormenzana M Monteoliva-Sánchez AM Fadda 2010 J Liposome Res 20 269 10.3109/08982100903402962
25. PE Grimes 1995 Arch Dermatol 131 1453 10.1001/archderm.1995. 01690240119022
26. AK Gupta MD Gover K Nouri S Taylor 2006 J Am Acad Dermatol 55 1048 10.1016/j.jaad.2006.02.009 (Pubitemid 44716465)
27. K Hac-Wydro K Jedrzejek P Dynarowicz-Łatka 2009 Colloids Surf B Biointerfaces 72 101 10.1016/j.colsurfb.2009.03.019
28. CC Hedli NR Rao KR Reuhl CM Witmer R Snyder 1996 Arch Toxicol 70 135 10.1007/s002040050252 (Pubitemid 26037731)
29. PL Honeywell-Nguyen S Arenja JA Bouwstra 2003 Pharm Res 20 1619 10.1023/A:1026191402557 (Pubitemid 37268278)
30. PL Honeywell-Nguyen JA Bouwstra 2003 J Control Release 86 145 10.1016/S0168-3659(02)00415-7 (Pubitemid 35469121)
31. K Ishiguro H Oku A Suitani Y Yamamoto 2002 Biol Pharm Bull 25 1655 10.1248/bpb.25.1655 (Pubitemid 39663690)
32. C Jewell S Cusack KD Cashman 2005 Prostaglandins Leukot Essent Fatty Acids 72 163 10.1016/j.plefa.2004.10.015 (Pubitemid 40139080)
33. MH Lee HJ Kim DJ Ha JH Paik HY Kim 2002 J Korean Med Sci 17 518
34. S Leekumjorn HJ Cho Y Wu NT Wright AK Sum C Chan 2009 Biochim Biophys Acta 1788 1508 10.1016/j.bbamem.2009.04.002
35. M Manconi C Sinico D Valenti G Loy AM Fadda 2002 Int J Pharm 234 237 10.1016/S0378-5173(01)00971-1 (Pubitemid 34142628)
36. V Nikolaou AJ Stratigos AD Katsambas 2006 J Cosmet Dermatol 5 303 10.1111/j.1473-2165.2006.00276.x (Pubitemid 44811459)
37. JL O'Donoghue 2006 J Cosmet Dermatol 5 196 10.1111/j.1473-2165.2006. 00253.x (Pubitemid 44314380)
38. D Paolino G Lucania D Mardente F Alhaique M Fresta 2005 J Control Release 106 99 10.1016/j.jconrel.2005.04.007 (Pubitemid 41140085)
39. L Pratsch A Herrmann K Arnold 1984 Biomed Biochim Acta 43 S85
40. Y Rao F Zheng X Zhang J Gao W Liang 2008 AAPS PharmSciTech 9 860 10.1208/s12249-008-9124-y
41. MI Rendon 2004 J Drugs Dermatol 3 S27
42. D Rigopoulos S Gregoriou A Katsambas 2007 J Cosmet Dermatol 6 195 10.1111/j.1473-2165.2007.00321.x (Pubitemid 47335281)
43. ML Rogerson BH Robinson S Bucak P Walde 2006 Colloids Surf B Biointerfaces 48 24 10.1016/j.colsurfb.2006.01.001
44. AC Rowat N Kitson JL Thewalt 2006 Int J Pharm 307 225 10.1016/j.ijpharm.2005.10.008 (Pubitemid 41820418)
45. P Santos AC Watkinson J Hadgraft ME Lane 2008 Skin Pharmacol Physiol 21 246 10.1159/000140228
46. A Schätzlein G Cevc 1998 Br J Dermatol 138 583 10.1046/j.1365-2133. 1998.02166.x (Pubitemid 28212240)
47. Y Shigeta H Imanaka H Ando A Ryu N Oku N Baba T Makino 2004 Skin whitening effect of linoleic acid is enhanced by liposomal formulations Biol Pharm Bull 27 591 10.1248/bpb.27.591 (Pubitemid 41701853)
48. Y Shigeta H Imanaka S Yonezawa N Oku N Baba T Makino 2004 Biol Pharm Bull 27 879 10.1248/bpb.27.879 (Pubitemid 41701808)
49. SI Simões CM Marques ME Cruz G Cevc MB Martins 2004 Eur J Pharm Biopharm 58 509 10.1016/j.ejpb.2004.05.010 (Pubitemid 39302554)
50. C Sinico C Caddeo D Valenti AM Fadda AR Bilia FF Vincieri 2008 J Liposome Res 18 83 10.1080/08982100801894067 (Pubitemid 351414948)
51. SP Soni JA Ward SE Sen SE Feller SR Wassall 2009 Biochemistry 48 11097 10.1021/bi901179r
52. E Touitou B Godin N Dayan C Weiss A Piliponsky F Levi-Schaffer 2001 Biomaterials 22 3053 10.1016/S0142-9612(01)00052-7 (Pubitemid 32768713)
53. E Touitou N Dayan L Bergelson B Godin M Eliaz 2000 J Control Release 65 403 10.1016/S0168-3659(99)00222-9 (Pubitemid 30122942)
54. E. Touitou, Patent WO 95/35095; A61K9/127, 7/00 (1995)
55. DD Verma S Verma G Blume A Fahr 2003 Eur J Pharm Biopharm 55 271 10.1016/S0939-6411(03)00021-3 (Pubitemid 36561553)
56. L Yang LK Leung Y Huang ZY Chen 2000 J Agric Food Chem 48 3072 10.1021/jf0003404